(Q37329147)

19 August 2017

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia (English)

1 reference

19 August 2017

Beckwith DG

1

1 reference

19 August 2017

Jahre JA

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 1980

1 reference

Journal of Clinical Microbiology

19 August 2017

1 reference

19 August 2017

12

1 reference

19 August 2017

517-520

1 reference

19 August 2017

4

1 reference

Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Lack of Correlation Between β-Lactamase Production and Susceptibility to Cefamandole or Cefoxitin Among Spontaneous Mutants of Enterobacteriaceae

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Carbenicillin plus cefamandole in the treatment of infections in patients with cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Efficacy and Safety of Cefamandole plus either Gentamicin or Tobramycin in Therapy of Severe Gram-Negative Bacterial Infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Cefamandole Nafate Therapy of Respiratory Tract, Skin, and Soft Tissue Infections in 74 Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Persistent gram-negative bacteremia. Observations in twenty patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Gram-negative bacteremia of long duration: Clinical study of 29 patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=273627

Simultaneous recovery of ampicillin-sensitive and ampicillin-resistant H. influenzae from blood

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6968320

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

19 August 2017

1 reference